Based on our previous findings that overexpression of mutant p53 increases mammary carcinoma cell aggressiveness and is associated with an EMT gene expression signature and reduction of CEACAM1-expression, we analyzed the specific molecular role of CEACAM1 in EMT and cancer progression [11, 18]. This evidence concerns the gene CEACAM1 and breast carcinoma.